Report Description

Global Remdesivir market is expected to reach USD9913.38 million by 2026. Remdesivir, a drug originally developed by Gilead Sciences, Inc. for the treatment of Ebola, is an antiviral medication belonging to the drug class of protease inhibitors. Remdesivir is a nucleotide analog particularly of adenosine, which shuts down the viral replication process by inhibiting the activity of an important viral enzyme RNA-dependent RNA polymerase. The drug basically causes mutation in viral genome and blocks polymerase enzymes function, which brings about premature termination of viral replication.

The global remdesivir market is driven by the increasing prevalence of COVID-19 pandemic across different parts of the globe. Remdesivir has been found to be effective in treating novel coronavirus disease patients across different parts of the globe. The Chinese have also been using the drug on compassionate use basis. Additionally, the drug was also used on the very first COVID-19 patient in the US, a young man in Snohomish country in Washington. He was given the drug when his condition worsened, and signs of improvement were observed on the very next day in his condition after the drug administration. A Californian patient, who the doctors thought, will not survive, also recovered after getting remdesivir. Promising results were also observed in Japan on 14 patients. After such cases and evidences, the US Food and Drug Administration granted approval to Remdesivir in Oct 2020 and the world is hoping that it will emerge out as a successful coronavirus treatment in coming years as well. 

The global remdesivir market is segmented based on dosage form, route of administration, patient age, distribution channel, application, company, and region. Based on dosage form, the market can be categorized into frozen solution, and lyophilized solution. The lyophilized segment is expected to hold significant market share on account of their longer shelf life. Additionally, they are cost effective, safe and an effective way to deliver medication.

Regionally, Asia Pacific is expected to witness significant growth during the forecast period in the overall remdesivir market owing to increasing number of COVID-19 patients and huge number of hospitalization cases along with increasing demand for remdesivir for the treatment of COVID-19.  

Major players operating in the global remdesivir market include Gilead Sciences, Inc., Cipla Ltd., Hetero Labs Ltd., Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.), Dr Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Jubilant Pharmova Ltd., Eva Pharma, Ferozsons Laboratories and others.

Years considered for this report:

Base Year: 2020

Estimated Year: 2021E

Forecast Period: 2022F–2026F

Objective of the Study:

  • To analyze and estimate the market size of global remdesivir market in 2020.
  • To estimate and forecast the market size of global remdesivir market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global remdesivir market based on dosage form, route of administration, patient age, application, distribution channel, company, and regional distribution.
  • To identify dominant region or segment in the global remdesivir market.
  • To identify drivers and challenges for global remdesivir market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global remdesivir market.
  • To conduct pricing analysis for global remdesivir market.
  • To identify and analyze the profile of leading players operating in global remdesivir market.
  • To identify key sustainable strategies adopted by market players in global remdesivir market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global remdesivir market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Remdesivir manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to remdesivir
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global remdesivir market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Remdesivir Market, By Dosage Form:
    • Lyophilized Solution
    • Frozen Solution
  • Global Remdesivir Market, By Route of Administration:
    • Intravenous
    • Inhalation
  • Global Remdesivir Market, By Patient Age:
    • Geriatric
    • Adult
    • Pediatric
  • Global Remdesivir Market, By Application:
    • SARS-CoV-2 (COVID-19)
    • MERS-CoV
    • Ebola
    • SARS-CoV
  • Global Remdesivir Market, By Distribution Channel:
    • Hospitals
    • Clinics
    • Drug Stores and Pharmacies
  • Global Remdesivir Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Asia-Pacific
      • India
      • Japan
      • China
      • South Korea
      • Australia
    • Europe
      • France
      • United Kingdom
      • Italy
      • Germany
      • Spain
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • Iran
      • South Africa
      • UAE
      • Saudi Arabia
      • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global remdesivir market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Remdesivir Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Brand Awareness (Aided/Unaided)

5.2.  Product Awareness

5.3.  Customer Satisfaction Analysis

5.4.  Unmet Needs/Challenges

6.    Global Remdesivir Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Dosage Form (Lyophilized Solution, Frozen Solution)

6.2.2.     By Route of Administration (Intravenous, Inhalation)

6.2.3.     By Patient Age (Geriatric, Adult, Pediatric)

6.2.4.     By Application (SARS-CoV-2 (COVID-19), MERS-CoV, Ebola, SARS-CoV)

6.2.5.     By Distribution Channel (Hospitals, Clinics, Drug Stores and Pharmacies)

6.2.6.     By Company (2020)

6.2.7.     By Region

6.3.  Product Market Map

7.    North America Remdesivir Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Dosage Form

7.2.2.     By Route of Administration

7.2.3.     By Patient Age

7.2.4.     By Application

7.2.5.     By Distribution Channel

7.2.6.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Remdesivir Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Dosage Form

7.3.1.2.2.             By Route of Administration

7.3.1.2.3.             By Patient Age

7.3.1.2.4.             By Application

7.3.1.2.5.             By Distribution Channel

7.3.2.     Mexico Remdesivir Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Dosage Form

7.3.2.2.2.             By Route of Administration

7.3.2.2.3.             By Patient Age

7.3.2.2.4.             By Application

7.3.2.2.5.             By Distribution Channel

7.3.3.     Canada Remdesivir Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Dosage Form

7.3.3.2.2.             By Route of Administration

7.3.3.2.3.             By Patient Age

7.3.3.2.4.             By Application

7.3.3.2.5.             By Distribution Channel

8.    Asia-Pacific Remdesivir Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Dosage Form

8.2.2.     By Route of Administration

8.2.3.     By Patient Age

8.2.4.     By Application

8.2.5.     By Distribution Channel

8.2.6.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     India Remdesivir Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Dosage Form

8.3.1.2.2.             By Route of Administration

8.3.1.2.3.             By Patient Age

8.3.1.2.4.             By Application

8.3.1.2.5.             By Distribution Channel

8.3.2.     Japan Remdesivir Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Dosage Form

8.3.2.2.2.             By Route of Administration

8.3.2.2.3.             By Patient Age

8.3.2.2.4.             By Application

8.3.2.2.5.             By Distribution Channel

8.3.3.     China Remdesivir Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Dosage Form

8.3.3.2.2.             By Route of Administration

8.3.3.2.3.             By Patient Age

8.3.3.2.4.             By Application

8.3.3.2.5.             By Distribution Channel

8.3.4.     South Korea Remdesivir Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Dosage Form

8.3.4.2.2.             By Route of Administration

8.3.4.2.3.             By Patient Age

8.3.4.2.4.             By Application

8.3.4.2.5.             By Distribution Channel

8.3.5.     Australia Remdesivir Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Dosage Form

8.3.5.2.2.             By Route of Administration

8.3.5.2.3.             By Patient Age

8.3.5.2.4.             By Application

8.3.5.2.5.             By Distribution Channel

9.    Europe Remdesivir Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Dosage Form

9.2.2.     By Route of Administration

9.2.3.     By Patient Age

9.2.4.     By Application

9.2.5.     By Distribution Channel

9.2.6.     By Country

9.3.  Europe: Country Analysis

9.3.1.     France Remdesivir Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Dosage Form

9.3.1.2.2.             By Route of Administration

9.3.1.2.3.             By Patient Age

9.3.1.2.4.             By Application

9.3.1.2.5.             By Distribution Channel

9.3.2.     United Kingdom Remdesivir Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Dosage Form

9.3.2.2.2.             By Route of Administration

9.3.2.2.3.             By Patient Age

9.3.2.2.4.             By Application

9.3.2.2.5.             By Distribution Channel

9.3.3.     Italy Remdesivir Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Dosage Form

9.3.3.2.2.             By Route of Administration

9.3.3.2.3.             By Patient Age

9.3.3.2.4.             By Application

9.3.3.2.5.             By Distribution Channel

9.3.4.     Germany Remdesivir Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Dosage Form

9.3.4.2.2.             By Route of Administration

9.3.4.2.3.             By Patient Age

9.3.4.2.4.             By Application

9.3.4.2.5.             By Distribution Channel

9.3.5.     Spain Remdesivir Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Dosage Form

9.3.5.2.2.             By Route of Administration

9.3.5.2.3.             By Patient Age

9.3.5.2.4.             By Application

9.3.5.2.5.             By Distribution Channel

10.  South America Remdesivir Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Dosage Form

10.2.2.  By Route of Administration

10.2.3.  By Patient Age

10.2.4.  By Application

10.2.5.  By Distribution Channel

10.2.6.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Remdesivir Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Dosage Form

10.3.1.2.2.           By Route of Administration

10.3.1.2.3.           By Patient Age

10.3.1.2.4.           By Application

10.3.1.2.5.           By Distribution Channel

10.3.2.  Argentina Remdesivir Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Dosage Form

10.3.2.2.2.           By Route of Administration

10.3.2.2.3.           By Patient Age

10.3.2.2.4.           By Application

10.3.2.2.5.           By Distribution Channel

10.3.3.  Colombia Remdesivir Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Dosage Form

10.3.3.2.2.           By Route of Administration

10.3.3.2.3.           By Patient Age

10.3.3.2.4.           By Application

10.3.3.2.5.           By Distribution Channel

11.  Middle East and Africa Remdesivir Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Dosage Form

11.2.2.  By Route of Administration

11.2.3.  By Patient Age

11.2.4.  By Application

11.2.5.  By Distribution Channel

11.2.6.  By Country

11.3.              MEA: Country Analysis

11.3.1.  Iran Remdesivir Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Dosage Form

11.3.1.2.2.           By Route of Administration

11.3.1.2.3.           By Patient Age

11.3.1.2.4.           By Application

11.3.1.2.5.           By Distribution Channel

11.3.2.  South Africa Remdesivir Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Dosage Form

11.3.2.2.2.           By Route of Administration

11.3.2.2.3.           By Patient Age

11.3.2.2.4.           By Application

11.3.2.2.5.           By Distribution Channel

11.3.3.  UAE Remdesivir Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Dosage Form

11.3.3.2.2.           By Route of Administration

11.3.3.2.3.           By Patient Age

11.3.3.2.4.           By Application

11.3.3.2.5.           By Distribution Channel

11.3.4.  Saudi Arabia Remdesivir Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Dosage Form

11.3.4.2.2.           By Route of Administration

11.3.4.2.3.           By Patient Age

11.3.4.2.4.           By Application

11.3.4.2.5.           By Distribution Channel

11.3.5.  Kuwait Remdesivir Market Outlook

11.3.5.1.      Market Size & Forecast

11.3.5.1.1.           By Value

11.3.5.2.      Market Share & Forecast

11.3.5.2.1.           By Dosage Form

11.3.5.2.2.           By Route of Administration

11.3.5.2.3.           By Patient Age

11.3.5.2.4.           By Application

11.3.5.2.5.           By Distribution Channel

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Pricing Analysis

15.  Patent Analysis

16.  Competitive Landscape

16.1.              Gilead Sciences, Inc.

16.2.              Cipla Ltd.

16.3.              Hetero Labs Ltd.

16.4.              Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.)

16.5.              Dr Reddy's Laboratories Ltd.

16.6.              Sun Pharmaceutical Industries Ltd.

16.7.              Cadila Healthcare Ltd.

16.8.              Jubilant Pharmova Ltd.

16.9.              Eva Pharma Ltd.

16.10.            Ferozsons Laboratories

17.  Strategic Recommendations

18.   About Us & Disclaimer

Figures and Tables

Figure 1:               Global Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 2:               Global Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 3:               Global Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 4:               Global Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 5:               Global Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 6:               Global Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 7:               Global Remdesivir Market Share, By Company, By Value, 2020

Figure 8:               Global Remdesivir Market Share, By Region, By Value, 2020-2026F

Figure 9:               Global Remdesivir Product Market Map, By Value, 2020-2026F

Figure 10:            North America Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 11:            North America Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 12:            North America Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 13:            North America Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 14:            North America Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 15:            North America Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 16:            North America Remdesivir Market Share, By Country, By Value, 2020-2026F

Figure 17:            United States Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 18:            United States Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 19:            United States Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 20:            United States Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 21:            United States Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 22:            United States Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 23:            Mexico Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 24:            Mexico Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 25:            Mexico Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 26:            Mexico Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 27:            Mexico Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 28:            Mexico Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 29:            Canada Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 30:            Canada Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 31:            Canada Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 32:            Canada Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 33:            Canada Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 34:            Canada Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 35:            Asia-Pacific Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 36:            Asia-Pacific Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 37:            Asia-Pacific Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 38:            Asia-Pacific Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 39:            Asia-Pacific Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 40:            Asia-Pacific Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 41:            Asia-Pacific Remdesivir Market Share, By Country, By Value, 2020-2026F

Figure 42:            India Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 43:            India Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 44:            India Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 45:            India Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 46:            India Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 47:            India Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 48:            Japan Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 49:            Japan Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 50:            Japan Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 51:            Japan Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 52:            Japan Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 53:            Japan Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 54:            China Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 55:            China Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 56:            China Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 57:            China Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 58:            China Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 59:            China Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 60:            South Korea Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 61:            South Korea Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 62:            South Korea Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 63:            South Korea Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 64:            South Korea Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 65:            South Korea Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 66:            Australia Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 67:            Australia Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 68:            Australia Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 69:            Australia Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 70:            Australia Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 71:            Australia Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 72:            Europe Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 73:            Europe Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 74:            Europe Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 75:            Europe Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 76:            Europe Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 77:            Europe Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 78:            Europe Remdesivir Market Share, By Country, By Value, 2020-2026F

Figure 79:            France Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 80:            France Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 81:            France Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 82:            France Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 83:            France Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 84:            France Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 85:            United Kingdom Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 86:            United Kingdom Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 87:            United Kingdom Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 88:            United Kingdom Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 89:            United Kingdom Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 90:            United Kingdom Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 91:            Italy Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 92:            Italy Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 93:            Italy Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 94:            Italy Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 95:            Italy Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 96:            Italy Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 97:            Germany Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 98:            Germany Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 99:            Germany Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 100:          Germany Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 101:          Germany Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 102:          Germany Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 103:          Spain Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 104:          Spain Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 105:          Spain Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 106:          Spain Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 107:          Spain Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 108:          Spain Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 109:          South America Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 110:          South America Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 111:          South America Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 112:          South America Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 113:          South America Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 114:          South America Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 115:          South America Remdesivir Market Share, By Country, By Value, 2020-2026F

Figure 116:          Brazil Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 117:          Brazil Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 118:          Brazil Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 119:          Brazil Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 120:          Brazil Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 121:          Brazil Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 122:          Argentina Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 123:          Argentina Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 124:          Argentina Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 125:          Argentina Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 126:          Argentina Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 127:          Argentina Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 128:          Colombia Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 129:          Colombia Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 130:          Colombia Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 131:          Colombia Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 132:          Colombia Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 133:          Colombia Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 134:          Middle East and Africa Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 135:          Middle East and Africa Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 136:          Middle East and Africa Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 137:          Middle East and Africa Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 138:          Middle East and Africa Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 139:          Middle East and Africa Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 140:          Middle East and Africa Remdesivir Market Share, By Country, By Value, 2020-2026F

Figure 141:          Iran Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 142:          Iran Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 143:          Iran Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 144:          Iran Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 145:          Iran Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 146:          Iran Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 147:          South Africa Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 148:          South Africa Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 149:          South Africa Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 150:          South Africa Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 151:          South Africa Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 152:          South Africa Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 153:          UAE Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 154:          UAE Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 155:          UAE Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 156:          UAE Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 157:          UAE Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 158:          UAE Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 159:          Saudi Arabia Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 160:          Saudi Arabia Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 161:          Saudi Arabia Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 162:          Saudi Arabia Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 163:          Saudi Arabia Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 164:          Saudi Arabia Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Figure 165:          Kuwait Remdesivir Market Size, By Value (USD Million), 2020-2026F

Figure 166:          Kuwait Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F

Figure 167:          Kuwait Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F

Figure 168:          Kuwait Remdesivir Market Share, By Patient Age, By Value, 2020-2026F

Figure 169:          Kuwait Remdesivir Market Share, By Application, By Value, 2020-2026F

Figure 170:          Kuwait Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Frequently asked questions

down-arrow

The main manufacturing company is Gilead Life Sciences that gained the Food and Drug Administration approval in 2020 for the administration of remdesivir for the treatment of COVID-19. Other players such as Cipla Ltd., Hetero Labs Ltd., Dr Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd. and Cadila Healthcare Ltd. have received license for manufacturing remdesivir in India.

down-arrow

The (FDA) has issued an Emergency Use Authorization (EUA) for the emergency use in the treatment of suspected or laboratory confirmed coronavirus disease 2019 (COVID-19) in hospitalized pediatric patients weighing 3.5 kg to less than 40 kg or hospitalized pediatric patients less than 12 years of age weighing at least 3.5 kg and adults

down-arrow

The recommended dosage for patients is a single loading dose of 200 mg on Day 1 followed by once-daily maintenance doses of 100 mg from Day 2

down-arrow

The increasing cases of COVID-19 and the need for better medication for the treatment of COVID-19 cases are driving the remdesivir market at global level

profile

Sakshi Bajaal

Business Consultant
Press Release

North America to Dominate the Global Remdesivir Market by 2026

Jul, 2021

Increasing number of COVID-19 patients across the globe to drive the growth of global remdesivir market.